Earnings Feed
Start Free
Ocuphire Pharma, Inc.·4

Nov 25, 7:26 PM ET

Sooch Mina 4

4 · Ocuphire Pharma, Inc. · Filed Nov 25, 2020

Insider Transaction Report

Form 4
Period: 2020-11-19
Ocuphire Pharma, Inc.OCUP
Sooch Mina
DirectorPresident and CEO
Transactions
  • Purchase

    Series B Warrant (right to buy)

    2020-11-19+2,046→ 2,046 total
    Exercise: $0.00From: 2020-11-19Exp: 2022-01-28→ Common Stock (2,046 underlying)
  • Purchase

    Common Stock

    2020-11-19+11,524→ 800,044 total
  • Purchase

    Series A Warrant (right to buy)

    2020-11-19+17,413→ 17,413 total
    Exercise: $4.48From: 2020-11-19Exp: 2025-11-19→ Common Stock (17,413 underlying)
Footnotes (2)
  • [F1]The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $65,000.
  • [F2]Subject to adjustment based on certain price reset provisions.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4